In summary, we demonstrated that BAFF depletion improved HFD-induced insulin resistance and liver steatosis via suppression of VAT inflammation and fibrosis, subsequently leading to beneficial VAT expansion. The gene discussed is TNFSF13B; the disease is Hepatic steatosis.